Oncorus Inc. (ONCR) NASDAQ

$5.44 -0.06 (-1.09%)

Market Cap: $141.95M

As of 11/30/21 10:54 AM EST. Market open.

(ONCR)

Oncorus Inc. (ONCR) NASDAQ

$5.44 -0.06 (-1.09%)

Market Cap: $141.95M

As of 11/30/21 10:54 AM EST. Market open.

At Oncorus, the company is focused on driving innovation to deliver next-generation viral immunotherapies to transform outcomes for cancer patients. Oncorus is advancing a portfolio of intratumorally and intravenously administered viral immunotherapies for multiple indications with significant unmet needs based on our oncolytic Herpes Simplex Virus (oHSV) Platform and Synthetic Virus Platform. ... read more

At Oncorus, the company is focused on driving innovation to deliver next-generation viral immunotherapies to transform outcomes for cancer patients. Oncorus is advancing a portfolio of intratumorally and intravenously administered viral immunotherapies for multiple indications with significant unmet needs based on our oncolytic Herpes Simplex Virus (oHSV) Platform and Synthetic Virus Platform. Designed to deliver next-generation viral immunotherapy impact, our oHSV platform improves upon key characteristics of this therapeutic class to enhance potency without sacrificing safety, including greater capacity to encode transgenes to drive systemic immunostimulatory activity, retention of full replication competency to enable high tumor-killing potency, and orthogonal safety strategies to restrict viral activity to tumor cells. Its lead program, ONCR-177, is designed to be directly administered into a tumor, resulting in high local concentrations of the therapeutic agent, as well as low systemic exposure to the therapy, which we believe could potentially limit systemic toxicities. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
56
Address
.
KEY STATS
Open
$5.44
Previous Close
$5.50
Days Range
$5.32 - $5.69
52 week range
$5.29 - $37.86
Volume
20,453
Avg. Volume (30 days)
445,308
Market Cap
$141.95M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
25,809,006
Open
$5.44
Previous Close
$5.50
Days Range
$5.32 - $5.69
52 week range
$5.29 - $37.86
Volume
20,453
Avg. Volume (30 days)
445,308
Market Cap
$141.95M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
25,809,006

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ONCORUS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Ashburn Theodore President and CEO Nov 19, 2021 Option Exercise $1.81 32,500 58,825 99,352 Nov 22, 2021, 06:30 AM
Harbin Stephen COO and Chief of Staff Nov 16, 2021 Buy $5.78 15,000 86,700 15,000 Nov 17, 2021, 04:05 PM
Harbin Stephen COO and Chief of Staff Nov 16, 2021 Buy $5.80 15,000 86,955 15,000 Nov 17, 2021, 04:05 PM
Ashburn Theodore President and CEO Oct 22, 2021 Option Exercise $1.81 43,707 79,110 66,852 Oct 25, 2021, 05:06 PM
Queva Christophe CSO and SVP, Research May 24, 2021 Option Exercise $1.81 35,561 64,365 71,181 May 26, 2021, 04:31 PM
Queva Christophe CSO and SVP, Research Apr 28, 2021 Sale $15.22 17,990 273,808 59,175 Apr 28, 2021, 07:32 PM
Queva Christophe CSO and SVP, Research Apr 27, 2021 Sale $15.00 211 3,165 77,165 Apr 28, 2021, 07:32 PM
Queva Christophe CSO and SVP, Research Apr 26, 2021 Sale $15.00 54 810 77,376 Apr 28, 2021, 07:32 PM
Ashburn Theodore President and CEO Dec 31, 2020 Option Exercise $1.81 1,900 3,439 18,446 Apr 09, 2021, 04:30 PM
Ashburn Theodore President and CEO Apr 07, 2021 Option Exercise $5.32 4,699 24,999 23,145 Apr 09, 2021, 04:30 PM
Queva Christophe CSO and SVP, Research Apr 06, 2021 Sale $15.01 5,300 79,553 77,430 Apr 08, 2021, 04:57 PM
Flynn James E Director Feb 17, 2021 Buy $19.00 133,558 2,537,602 1,401,905 Feb 18, 2021, 06:44 PM
Flynn James E Director Feb 17, 2021 Buy $19.00 32,884 624,796 345,167 Feb 18, 2021, 06:44 PM
Flynn James E Director Feb 17, 2021 Buy $19.00 133,558 2,537,602 1,401,905 Feb 18, 2021, 06:44 PM
MPM SunStates Fund, L.P. 10% Owner Oct 06, 2020 Buy $15.00 173,776 2,606,640 2,849,453 Oct 08, 2020, 06:35 PM
MPM BioVentures 2014, L.P. 10% Owner Oct 06, 2020 Buy $15.00 173,776 2,606,640 2,849,453 Oct 08, 2020, 06:31 PM
GADICKE ANSBERT 10% Owner Oct 06, 2020 Buy $15.00 325,000 4,875,000 2,849,453 Oct 08, 2020, 06:28 PM
EVNIN LUKE Director Oct 06, 2020 Buy $15.00 151,225 2,268,375 2,492,843 Oct 08, 2020, 06:27 PM
UBS Oncology Impact Fund L.P. 10% Owner Oct 06, 2020 Buy $15.00 151,224 2,268,360 2,377,025 Oct 08, 2020, 06:26 PM
Flynn James E Director Oct 06, 2020 Buy $15.00 445,194 6,677,910 1,268,344 Oct 08, 2020, 05:31 PM
Flynn James E Director Oct 06, 2020 Buy $15.00 109,612 1,644,180 312,282 Oct 08, 2020, 05:31 PM
Flynn James E Director Oct 06, 2020 Buy $15.00 445,194 6,677,910 1,268,344 Oct 08, 2020, 05:31 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Ashburn Theodore President and CEO 11/19/2021 58,825
Harbin Stephen COO and Chief of Staff 11/16/2021 86,700
Harbin Stephen COO and Chief of Staff 11/16/2021 86,955
Ashburn Theodore President and CEO 10/22/2021 79,110
Queva Christophe CSO and SVP, Research 05/24/2021 64,365
Queva Christophe CSO and SVP, Research 04/28/2021 273,808
Queva Christophe CSO and SVP, Research 04/27/2021 3,165
Queva Christophe CSO and SVP, Research 04/26/2021 810
Ashburn Theodore President and CEO 12/31/2020 3,439
Ashburn Theodore President and CEO 04/07/2021 24,999
Queva Christophe CSO and SVP, Research 04/06/2021 79,553
Flynn James E Director 02/17/2021 2,537,602
Flynn James E Director 02/17/2021 624,796
Flynn James E Director 02/17/2021 2,537,602
MPM SunStates Fund, L.P. 10% Owner 10/06/2020 2,606,640
MPM BioVentures 2014, L.P. 10% Owner 10/06/2020 2,606,640
GADICKE ANSBERT 10% Owner 10/06/2020 4,875,000
EVNIN LUKE Director 10/06/2020 2,268,375
UBS Oncology Impact Fund L.P. 10% Owner 10/06/2020 2,268,360
Flynn James E Director 10/06/2020 6,677,910
Flynn James E Director 10/06/2020 1,644,180
Flynn James E Director 10/06/2020 6,677,910
Load More Insider Transactions